Gene: UBR5
Official Full Name: ubiquitin protein ligase E3 component n-recognin 5provided by HGNC
Gene Summary: This gene encodes a progestin-induced protein, which belongs to the HECT (homology to E6-AP carboxyl terminus) family. The HECT family proteins function as E3 ubiquitin-protein ligases, targeting specific proteins for ubiquitin-mediated proteolysis. This gene is localized to chromosome 8q22 which is disrupted in a variety of cancers. This gene potentially has a role in regulation of cell proliferation or differentiation. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03853 | UBR5 Knockout cell line (HeLa) | Human | UBR5 | 1:3~1:6 | Negative | Online Inquiry |
KO03854 | UBR5 Knockout cell line (HCT 116) | Human | UBR5 | 1:2~1:4 | Negative | Online Inquiry |
KO03855 | UBR5 Knockout cell line (HEK293) | Human | UBR5 | 1:3~1:6 | Negative | Online Inquiry |
KO03856 | UBR5 Knockout cell line (A549) | Human | UBR5 | 1:3~1:4 | Negative | Online Inquiry |
UBR5 Gene Knockout Cell Lines are specifically engineered cellular models designed to systematically eliminate the expression of the UBR5 gene, which encodes the Ubiquitin Protein Ligase E3 component. This knockout mechanism leverages the principles of CRISPR/Cas9 technology or other gene-editing techniques to create cells that exhibit a complete absence of UBR5 activity. By understanding the role of UBR5 in post-translational protein regulation and cellular processes such as cell cycle progression, apoptosis, and DNA repair, researchers can gain invaluable insights into the gene's function and its implications in various diseases, including cancer.
The UBR5 role in the ubiquitin-proteasome system is particularly significant, as it directs the degradation of specific target proteins, thereby influencing signaling pathways pivotal for cellular homeostasis. With these knockout cell lines, scientists can explore the phenotypic consequences of UBR5 deficiency, elucidating its potential involvement in pathological states. Furthermore, these models serve as robust platforms for testing therapeutic interventions aimed at correcting dysregulated pathways that involve UBR5, thus facilitating the development of novel treatment strategies.
One of the standout features of our UBR5 Gene Knockout Cell Lines is their robustness and reliability, validated through rigorous characterization protocols. Compared to alternative cell lines, our models offer a higher fidelity in recapitulating the physiological conditions of UBR5 deficiency, enhancing the translation of preclinical findings to clinical applications. Additionally, they are compatible with high-throughput screening, making them an essential resource for drug discovery and functional genomics studies.
Incorporating UBR5 Gene Knockout Cell Lines into your research toolkit empowers you with the means to contribute to cutting-edge discoveries in cell biology and therapeutic development. Our company prides itself on its commitment to delivering high-quality biological products backed by our extensive expertise in genetics and cellular technologies, ensuring that researchers and clinicians have access to the best tools for their scientific pursuits.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.